Skip to content

Impact of Oncogeriatric Consultation on Quality of Life of Patients Aged 75 and More With Cancer

Impact of Oncogeriatric Consultation on Quality of Life of Patients Aged 75 and More With Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05163015
Acronym
ONCOGERIA-QDV
Enrollment
60
Registered
2021-12-20
Start date
2022-01-04
Completion date
2022-08-01
Last updated
2022-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Cancers, aged patients, oncogeriatric consultation, quality of life

Brief summary

Among patients with cancer, 6 in 10 are over 65 years of age. In order to improve quality of life of aged cancer patients, the oncogeriatric consultation has been created. Oncogeriatric consultation aim to help oncologists determine the best solutions to combine therapy and quality of life. Factors influencing quality of life of cancer patients have been studied previously. However, these studies always focus on one specific cancer.

Detailed description

The aim of the study is to study factors associated with quality of life in patients aged 75 and more with cancer, notably the oncogeriatric consultation.

Interventions

OTHERData collection

Description: quality of life assessment

Sponsors

Université de Reims Champagne-Ardenne
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* male or female * aged of 75 and more * with cancer * with indication of oncogeriatric consultation according G8 * agreeing to participate in the study

Exclusion criteria

-less than 75 years old

Design outcomes

Primary

MeasureTime frameDescription
EORTC QLQ-C30Day 0The QLQ-C30 is a generic questionnaire with 30 questions coded in 4 response modalities (not at all (1), a little (2), enough (3), a lot (4)) or in 7 response modalities (from very bad (1) to excellent ( 7)). Questions are summarized in five multiitem domains (physical, role, cognitive, emotional, and social functioning) and nine single item domains (fatigue, pain, nausea/vomiting, appetite loss, financial impact; diarrhea, constipation, sleep disturbance and quality of life). Each domain is scored between 0 and 100. For functional domains, a high score value represents a high level of quality of life. For symptom domains, a high score represents an important level of symptoms (a low level of quality of life).

Countries

France

Contacts

Primary ContactCURRS
currs@univ-reims.fr0326918822
Backup ContactCoralie BARBE, MD
currs@univ-reims.fr0326918822

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026